Synchron
Cholesterol Reagent (CHOL 2 x 300)
9manufacturers in China registered for this device type
1catalogue number
4recalls on this code
Who Else Makes It
Concentrated in Zhejiang (4), Shandong (1), Guangxi (1). 2 of them are registered as contract manufacturers, able to build to a buyer’s own specification.
| Manufacturer | City | Province | Registered as | Device types |
|---|---|---|---|---|
| Acon Biotech (Hangzhou) Co., Ltd. | Hangzhou | Zhejiang | Contract manufacturer | 29 |
| Dongguan BAO Kang Dian ZI KE JI Limited | Dongguan | Guangdong | Contract manufacturer | 24 |
| Zhejiang Orient Gene Biotech | Huzhou | Zhejiang | Contract manufacturer | 86 |
| Biobase Biodustry(Shandong)Co., Ltd. | Jinan | Shandong | Manufacturer | 70 |
| Urit Medical Electronic Co., Ltd. | Guilin | Guangxi | Contract manufacturer | 28 |
| Shijiazhuang Hipro Biotechnology Co., Ltd. | Shijiazhuang | Hebei | Manufacturer | 22 |
| Hangzhou Lysun Biotechnology Co., Ltd. | Hangzhou | Zhejiang | Manufacturer | 22 |
| Eaglenos Sciences, Inc. | Nanjing | Jiangsu | Manufacturer | 4 |
| Medicalsystem Biotechnology Co., Ltd. | Ningbo | Zhejiang | Manufacturer | 1 |
Record
| Listed by | Beckman Coulter, Inc., United States |
|---|---|
| FDA product code | CHH |
| Device type | Enzymatic Esterase–Oxidase, Cholesterol |
| Device class | Class 1 |
| Regulation | 21 CFR 862.1175 |
| Establishment | Contract manufacturer, Specification developer, Manufacturer, Exporter |
| Premarket notification | Exempt |
| Record published | 2016-08-24 |
| Record revised | 2023-07-06 (version 3) |
Specifications
| MRI safety | Labeling does not contain MRI Safety Information |
|---|---|
| Single use | Yes |
| Prescription | Prescription only |
| Supplied as a kit | Yes |
| Label carries | lot or batch number, expiry date, manufacturing date |
Catalogue Numbers
| Catalogue number | Size | Status |
|---|---|---|
| 467825 | In distribution |
Same Product Code
| Product | Sold by | Catalogue numbers |
|---|---|---|
| Fora | Fora Care Inc. | 8 |
| Synermed® | Infrared Laboratory Systems LLC | 7 |
| JAS Diagnostics | Drew Scientific, Ltd. | 7 |
| Standard™ LipidoCare Lipid Test Strip – Lipid Profile | SD Biosensor, Inc. | 4 |
| Pointe Scientific, Inc. | Horiba Instruments Incorporated | 4 |
| Biobase | Biobase Biodustry(Shandong)Co., Ltd. | 4 |
| Carolina Liquid Chemistries Corp.® Cholesterol Reagent KIT BL211 | Carolina Liquid Chemistries | 4 |
| Cholesterol Gen.2 | Roche Diagnostics Gmbh | 3 |
| AU | Beckman Coulter, Inc. | 3 |
| Pointe Scientific, Inc. Cholesterol | Horiba Instruments Incorporated | 3 |
| Cholestech LDX™ | Alere San Diego, Inc. | 3 |
| Pointe Scientific Cholesterol (Liquid) | Horiba Instruments Incorporated | 3 |
Showing 12 of 77. All products under Enzymatic Esterase–Oxidase, Cholesterol
Recalls Naming This Product
1 recall names this product by its own identifier, the UDI on its label.
| Recalled by | Identified by | Initiated | FDA class | Root cause | Reason | Quantity |
|---|---|---|---|---|---|---|
| Beckman Coulter, Inc. | UDI-DI | 2021-11-10 | Class II | Nonconforming Material/Component | Cholesterol Reagent may fail with Out of Calibration Range Low (OCR Low) and/or Back to Back (B/B) errors. Low quality control recovery failures may be observed after passing calibration. Brown particulates in compartment C of the reagent c | 1433 |
Recalls
3 of these are Class II. Class II means a temporary or reversible health consequence. Volume alone is not a quality signal: a manufacturer that ships more recalls more.
| Initiated | FDA class | Root cause | Reason | Quantity | Closed |
|---|---|---|---|---|---|
| 2017-04-03 | Class II | Under Investigation by firm | Beckman Coulter has identified the following drugs as potential sources of interference: Metamizole (Dipyrone), Sulfasalazine, and Sulfapyridine and may result in false low results. | 128,718 units total (47,858 units in US) | 2018-05-31 |
| 2016-04-13 | Class II | Device Design | Beckman Coulter has identified that Dipyrone (Metamizole) may cause erroneous, false low results in the following assays: Cholesterol OSR6X16, Triglyceride OSR6X118, Uric Acid OSR6X98, Lactate OSR6X93, and Lipase OSR6X30. | 43,877 units total (10,496 units in US) | 2016-06-30 |
| 2014-12-15 | Class II | Under Investigation by firm | N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations for the treatment of acetaminophen overdose, interferes with the assays for these analytes: Cholesterol OSR6X16, Uric Acid OSR6X98, Lactate OSR6X93, and Lipase OSR6X30 | 59,965 units total (21,782 units in US) | 2016-02-19 |
Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.